Loading…
Profound Medical Corp. is projected to rise to $8.22 by 2027, a +20% move from its current price of $6.87. PROF is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.69 | $6.87 | $7.06 | +0.06% |
| May 30 | $6.62 | $6.88 | $7.14 | +0.11% |
| May 31 | $6.57 | $6.88 | $7.21 | +0.17% |
| Jun 1 | $6.53 | $6.89 | $7.26 | +0.22% |
| Jun 2 | $6.49 | $6.89 | $7.31 | +0.28% |
| Jun 3 | $6.46 | $6.89 | $7.36 | +0.33% |
| Jun 4 | $6.43 | $6.90 | $7.40 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.43 | $6.90 | $7.40 | +0.39% |
| Week 2 | $6.27 | $6.92 | $7.65 | +0.78% |
| Week 3 | $6.15 | $6.95 | $7.85 | +1.17% |
| Week 4 | $6.06 | $6.98 | $8.03 | +1.56% |
| Week 5 | $5.98 | $7.00 | $8.20 | +1.95% |
| Week 6 | $5.92 | $7.03 | $8.36 | +2.35% |
| Week 7 | $5.86 | $7.06 | $8.51 | +2.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. Its lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.
It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland.
Profound Medical Corp. is headquartered in Mississauga, Canada.
Profound Medical Corp. trades under the ticker PROF and is categorized in Healthcare as a medical devices company. The stock’s current price is $6.83 with a market cap of $248.19M, and it ranks 3675 by market capitalization.
The technical setup shows a bullish flavor in the near term, with a RSI of 50 and moving averages at SMA50 $6.49 and SMA200 $6.30. Near-term support sits at $6.26 while resistance is at $7.27, and the 30-day range stretches from $5.68 to $8.22. Annualized volatility is 50%.
The year-by-year forecast implies an upside path over time, with a neutral stance in 2026 and progressively higher averages thereafter, culminating in substantial long-run upside.
A major floor 26.3% below — a decisive break under it would weaken the trend.
The nearest floor, 6.6% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 19.7% above — clearing it would confirm fresh momentum.
Key PROF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PROF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.87 | Sell | $6.86 | Buy |
| MA 10 | $6.92 | Sell | $6.90 | Sell |
| MA 20 | $6.95 | Sell | $6.88 | Sell |
| MA 50 | $6.54 | Buy | $6.76 | Buy |
| MA 100 | $6.85 | Buy | $6.68 | Buy |
| MA 200 | $6.31 | Buy | $6.56 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.62 | Neutral |
| Stoch RSI (14) | 25.01 | Neutral |
| CCI (20) | -29.48 | Neutral |
| Williams %R (14) | -73.08 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 0.29 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 26.92 | Neutral |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 44.24 | Neutral |
| Momentum (10) | -0.27 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 6.82 | Buy |
| ADX (14) | 8.37 | Neutral |
| ATR (14) | 0.16 | Info |
Near-term technical picture is bullish sentiment. The RSI14 is 50, indicating neither overbought nor oversold pressure, while the SMA50 is $6.49 and the SMA200 is $6.30, suggesting a constructive trend if price remains above these moving averages.
The stock faces a defined nearby range with a support level at $6.26 and a resistance at $7.27. The 30-day price range runs from $5.68 to $8.22, offering potential for range-bound movement in the short term. Volatility stands at 50% on an annualized basis, indicating meaningful price swings relative to the price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.06 | $6.87 | $9.36 | 0% | Neutral | |
| $6.53 | $8.22 | $10.94 | +20% | Neutral | |
| $7.68 | $9.92 | $13.68 | +44% | Bullish | |
| $9.40 | $12.41 | $17.59 | +81% | Bullish | |
| $10.02 | $13.49 | $19.58 | +96% | Bullish | |
| $10.37 | $14.22 | $21.06 | +107% | Bullish | |
| $10.58 | $14.74 | $22.24 | +115% | Bullish | |
| $10.99 | $15.56 | $23.87 | +127% | Bullish | |
| $13.43 | $19.30 | $30.07 | +181% | Bullish | |
| $15.10 | $22.01 | $34.78 | +220% | Bullish | |
| $19.58 | $30.45 | $51.11 | +343% | Bullish | |
| $35.37 | $61.45 | $112.65 | +795% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.06 | $6.87 | $8.05 | +0.00% |
| June 2026 | $5.96 | $6.99 | $8.40 | +1.75% |
| July 2026 | $6.11 | $7.23 | $8.79 | +3.36% |
| August 2026 | $6.03 | $7.18 | $8.83 | -0.65% |
| September 2026 | $6.01 | $7.20 | $8.92 | +0.25% |
| October 2026 | $6.24 | $7.51 | $9.37 | +4.29% |
| November 2026 | $6.30 | $7.61 | $9.56 | +1.38% |
| December 2026 | $6.10 | $7.40 | $9.36 | -2.73% |
Click any year to see its month-by-month PROF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PROF price prediction for 2026 points to an average of $6.87 (low $5.06, high $9.36) — a potential gain of 0% on today's $6.87. Price action looks broadly range-bound.
In 2027, PROF is projected to trade between $6.53 and $10.94, averaging $8.22 — a potential gain of +20% from today's $6.87. That is up +20% on the projected 2026 average. A consolidation phase looks the most probable path here.
Profound Medical Corp.'s 2028 outlook centres on $9.92, within a $7.68 to $13.68 range. That is up +21% on the projected 2027 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2029, PROF could reach as high as $17.59, with a base case around $12.41 and support toward $9.40 — roughly +81% from $6.87. Buyers look set to stay in control over this stretch.
Expect PROF to range from $10.02 to $19.58 through 2030. The $13.49 average target implies a +96% move from current prices. That is up +9% on the projected 2029 average. Momentum favours further upside here.
The PROF price prediction for 2031 points to an average of $14.22 (low $10.37, high $21.06) — a potential gain of +107% on today's $6.87. Buyers look set to stay in control over this stretch.
In 2032, PROF is projected to trade between $10.58 and $22.24, averaging $14.74 — a potential gain of +115% from today's $6.87. That is up +4% on the projected 2031 average. Momentum favours further upside here.
Profound Medical Corp.'s 2033 outlook centres on $15.56, within a $10.99 to $23.87 range. That is up +6% on the projected 2032 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PROF could reach as high as $30.07, with a base case around $19.30 and support toward $13.43 — roughly +181% from $6.87. Momentum favours further upside here.
Expect PROF to range from $15.10 to $34.78 through 2035. The $22.01 average target implies a +220% move from current prices. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PROF price prediction for 2040 points to an average of $30.45 (low $19.58, high $51.11) — a potential gain of +343% on today's $6.87. Momentum favours further upside here.
In 2050, PROF is projected to trade between $35.37 and $112.65, averaging $61.45 — a potential gain of +795% from today's $6.87. That is up +102% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PROF today (≈ 145.560408 PROF) could be worth
$8,945.38
+$7,945.38 (+795%) by 2050 · US Dollar
Based on the average projected PROF price of $61.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PROFwould be worth at today's price.
$1,000 invested in PROF on May 27, 2025 (≈ 189.573456 PROF) would be worth
$1,302.37
+$302.37 (+30.2%) today · 1.30× · US Dollar
Based on a PROF entry price of $5.28 vs. today's $6.87.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.92 | $992.77 | -0.7% |
| 1 month ago | $6.75 | $1,017.78 | +1.8% |
| 3 months ago | $7.78 | $883.6 | -11.6% |
| 6 months ago | $6.6 | $1,040.91 | +4.1% |
| 1 year ago | $5.28 | $1,302.37 | +30.2% |
| All time (5.0y) ago | $17.52 | $392.12 | -60.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PROF forecast.
Our base-case forecast reaches $14.00 around 2031.
Implied market cap at $14.00: $508.73M
The multi-year forecast paints a clear path of rising averages and sizable upside, with the 2026 average at $6.83 and a neutral sentiment. The sequence then builds to stronger gains: 2027 avg $8.15 (ROI 19.3%), 2028 avg $9.76 (ROI 42.9%), 2029 avg $12.27 (ROI 79.6%), and 2030 avg $13.37 (ROI 95.7%), all with a bullish outlook.
Looking further out, 2031 avg $13.85 (ROI 102.8%), 2032 avg $14.35 (ROI 110.1%), 2033 avg $15.22 (ROI 122.8%), 2034 avg $18.71 (ROI 174%), and 2035 avg $21.41 (ROI 213.5%), all bullish.
The forecast accelerates to 2040 with an avg of $29.31 (ROI 329.1%) and to 2050 with an avg of $58.85 (ROI 761.6%), both labeled BULLISH. Bearish or uncertain conditions are not indicated in the long-term forecast; these are estimates and not guarantees, and actual results may differ due to market and company-specific factors.
Tap a question to reveal the answer.
2030 avg $13.37; min $9.83; max $19.62; ROI 95.7%; sentiment BULLISH.
Forecasts show upside across years, with 2027 avg $8.15 (ROI 19.3%), 2028 avg $9.76 (ROI 42.9%), 2029 avg $12.27 (ROI 79.6%), 2030 avg $13.37 (ROI 95.7%), and 2040 avg $29.31 (ROI 329.1%), culminating in 2050 avg $58.85 (ROI 761.6%). Sentiment turns bullish from 2027 onward, but these are estimates and not guarantees.
The forecast shows a max of $19.62 in 2030, $110.06 as the 2050 max, indicating that a $100 level would be reached only by 2050 per the provided max forecast.
Current price is $6.83 and market cap is $248.19M.
Bullish sentiment with RSI 50. The 30-day range is $5.68 to $8.22, with support at $6.26 and resistance at $7.27.
Profound Medical Corp. Community Discussion
0Share your Profound Medical Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.